In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

The failure of clinical trials using gamma-secretase inhibitors ... the researchers will carry out more research on cellular homeostasis in the early phases of AD and will collaborate with colleagues ...

Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...

The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...

Classic psychedelics, some advocates argue, come with too much baggage. But these altered, “next generation” medications may ...

NXC-201 is the only CAR-T therapy currently in development in AL Amyloidosis, mentioned in a review article entitled “Systemic Light Chain Amyloidosis” published in June, 2024 New England Journal of ...

Your brain can’t always tell the difference between a jump scare and a real threat. But what’s thrilling for some people can ...

Charlotte’s new medical school and innovation district: a "surgical ballroom," anatomy without cadavers & more ...

Related: How to Know If You're Co-Parenting With a Narcissist "We all have narcissistic aspects to our personality that help build self-esteem and self-worth," explains Jeanette Raymond, PhD, a ...

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...

A new thought piece led by the Harvard Pilgrim Health Care Institute with collaborators from Duke University and Kaiser Permanente Washington Health Research Institute highlights the challenges facing ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...